Article

Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency

2024-04-01

Abstract excerpt

<title>Abstract</title> <p>We analyzed genomic data derived from the prostate cancer of African and European American men in order to identify differences that may contribute to racial disparity of outcome and that could also define novel therapeutic strategies. In addition to analyzing patient derived next generation sequencing data, we performed FISH based confirmatory studies of Chromodomain helicase DNA-bindi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 916def84-57d7-52a0-aebd-d00173bcf1fb
DOI: 10.21203/rs.3.rs-3995251/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiencyDOI 10.21203/rs.3.rs-3995251/v1Read

Subclonal<i>CHD1</i>deletion is more frequent in African American prostate cancers and associated with rapid disease progression and limited levels of homologous recombination deficiencySemantic proximity Read

CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair.Semantic proximity Read

The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.Semantic proximity Read

Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes.Semantic proximity Read

Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.Semantic proximity Read

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.Semantic proximity Read

Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patientsSemantic proximity Read

CHD1, a multifaceted epigenetic remodeler in prostate cancerSemantic proximity Read

BRCA2 reversion mutation-independent resistance to PARP inhibition in prostate cancer through loss of function perturbations in the DNA pre-replication complexSemantic proximity Read

Mutational and functional heterogeneity of homology-directed repair deficiency and clinical implicationsSemantic proximity Read

Frequent Disruption of Chromodomain Helicase DNA-Binding Protein 8 (CHD8) and Functionally Associated Chromatin Regulators in Prostate CancerSemantic proximity Read

Increased Incidence of DACH1 Mutation in Appalachian Women with Uterine Cancer and Altered Chemotherapy SensitivitySemantic proximity Read